UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept.
Merck, known as MSD outside the United States and Canada, announced that is...
by Lee Han-soo
|
2018-10-11 16:31
라인
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
Celltrion said Thursday that the U.S. Oncologic Drug Advisory Committee (OD...
by Lee Han-soo
|
2018-10-11 12:10
라인
‘Korea publishes many biotech papers but rarely links them to biz’
South Korea’s ranking in biotech competitiveness, announced by the U.S. sci...
by Nam Doo-hyun
|
2018-10-10 16:35
라인
GC opens new cell research center
GC said Monday that it has dedicated a new integrated research center in a ...
by Lee Han-soo
|
2018-10-10 11:45
라인
More biotech stocks come in top 20 on KOSDAQ
The number of pharmaceutical and biotech firms within the top 20 companies ...
by Nam Doo-hyun
|
2018-10-10 11:20
라인
Newly listed biotech firms perform poorly on KOSDAQ
Biotech companies that went public in the first half of this year have show...
by Nam Doo-hyun
|
2018-10-04 13:09
라인
‘Samsung C&T’s value to rise on BioLogics’ increased value’
Samsung C&T Corp., the parent company of Samsung Group, is likely to enjoy ...
by Nam Doo-hyun
|
2018-10-03 10:11
라인
More doctoral degree holders wanted at biotech ventures
Korean biotech venture companies are increasingly seeking more Ph.D.-qualif...
by Nam Doo-hyun
|
2018-10-02 14:40
라인
FDA to review Samsung Bioepis’ application for anti-arthritis biosimilar
Samsung Bioepis said Thursday that the U.S. Food and Drug Administration ha...
by Lee Han-soo
|
2018-09-27 11:22
라인
Biois registers patent to develop TNF-alpha inhibitor
Biois Corp. said it has registered a patent on aptamers binding to tumor ne...
by So Jae-hyeon
|
2018-09-20 16:45
라인
Celltrion, Emory University to develop new drug for Atherosclerosis
Celltrion said Thursday that it has signed an “incubation” agreement with E...
by Lee Han-soo
|
2018-09-20 13:22
라인
FDA approves Bifido’s strain as new dietary ingredient
Bifido, a local microbiome company, said Tuesday that the U.S. Food and Dru...
by Lee Han-soo
|
2018-09-18 17:14
라인
Nature Cell shares spike despite investment alert warning
Industry watchers are looking for answers why shares of Nature Cell have be...
by Nam Doo-hyun
|
2018-09-14 16:08
라인
GC Cell shares spike on winning FDA nod for Immuncell-LC
Stock prices of GC Cell and ToolGen went in the opposite direction on Wedne...
by Nam Doo-hyun
|
2018-09-12 16:05
라인
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’
The biotech industry is paying close attention to how the recent controvers...
by So Jae-hyeon
|
2018-09-12 14:25
라인
‘ToolGen’s KOSDAQ listing might be in peril’
ToolGen, a local biotech firm specialized in gene editing, has been mired i...
by Nam Doo-hyun
|
2018-09-10 14:59
라인
‘Pharmaceutical stocks to bottom out soon’
Korean pharmaceutical and biotech shares are expected to have an upward tre...
by Nam Doo-hyun
|
2018-08-29 14:34
라인
Celltrion completes P3 clinical trials for Remsima in Europe
Celltrion said it has completed phase 3 clinical trial for Remsima SC, the ...
by Lee Han-soo
|
2018-08-29 14:33
라인
Merck to globally distribute T&R Biofab’s bio-ink
T&R Biofab said Wednesday that it has signed an original equipment manufact...
by Lee Han-soo
|
2018-08-22 12:30
라인
Biotech firms grudge over regulator’s plan to toughen disclosure rules
Pharmaceutical and biotech industry officials are expressing discontent ove...
by So Jae-hyeon
|
2018-08-17 11:51
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top